Cardiovascular
Panasonic Makes Investment in Houston-based CardioNexus Corp.
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsSECAUCUS, N.J., Oct. 25 /- Panasonic Corporation of North America has completed an investment in CardioNexus Corporation, a portfolio company of Houston's Fairway Medical Technologies which works closely with the Texas Medical Center. The move is part of Panasonic's plans to establish...
10 Tips for Breast Cancer Survivors
October 22, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsSEATTLE, Oct. 22 /- Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening...
Social interaction can identify mental pathology
October 22, 2010 7:32 am | by Baylor College of Medicine | News | CommentsIf your doctor thinks your blood pressure is too high, she can measure it with an instrument. If she thinks you are anemic, she can order a lab test. Psychiatrists seeking to identify mental disorders must depend on less precise measures – observations of behaviors and various...
Children's Hospital granted $3M to study rare blood disease
October 22, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | News | CommentsChildren’s Hospital Boston has received a $3.9 million grant from the National Institutes of Health to work on a treatment on a fatal genetic blood disease called Fanconi anemia.
Thoratec Schedules Third Quarter Conference Call, Webcast
October 22, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsPLEASANTON, Calif., Oct. 22 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter and first nine months...
New Label Changes for Commonly Prescribed HIV Drug Invirase
October 21, 2010 12:32 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Oct. 21 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when...
DNA minivectors provide new gene therapy tool
October 21, 2010 3:33 am | by Baylor College of Medicine | News | CommentsTiny wound-up circular bits of DNA that carry a short "hairpin" of RNA could prove a solution to the quest for a non-toxic, long-lived gene therapy vector designed to silence cancer genes in tumor cells, said researchers from Baylor College of Medicine and The Methodist Hospital Research...
FDA approves Boehringer Ingelheim blood clot treatment
October 20, 2010 5:33 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsThe U.S. Food and Drug Administration has approved Pradaxa, a drug developed by Boehringer Ingelheim Corp. to lower the risk of stroke and blood clots in patients with irregular heartbeats.
Beaumont Hospital Opens New Ernst Cardiovascular Center
October 20, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsROYAL OAK, Mich., Oct. 20 /- Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak. Specialty clinics in the new Ernst Cardiovascular Center offer breakthrough...
Patient Experience Research Grants Awarded
October 19, 2010 11:31 am | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 19 /- As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues. (Logo:...
MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
October 19, 2010 7:33 am | by Bio-Medicine.Org | News | CommentsWOONSOCKET, R.I., Oct. 19 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western...
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
October 19, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 19 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that Rod Kenley has been appointed to the Aethlon Medical board of directors. (Photo:...
UT Southwestern Doctor's Expertise Helped Trapped Chilean Miners During Pressured Half-Mile-Deep Rescue(2)
October 18, 2010 4:33 pm | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 18 /PRNewswire-USNewswire/ -- When rescuers needed to determine how to safely extract Chilean miners without their fainting and suffering a potentially devastating loss of blood to the brain, they turned to a UT Southwestern Medical Center scientist whose expertise typically...
Reportlinker Adds Global Minimally Invasive Surgery Market.(2010 - 2015)
October 18, 2010 3:33 pm | by Bio-Medicine.Org | News | CommentsNEW YORK, Oct. 18 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Minimally Invasive Surgery Market.(2010 - 2015) http://www.reportlinker.com/p0316089/Global-Minimally-Invasive-Surgery-M... Global Minimally Invasive...
Abaxis to Report Second Quarter Fiscal 2011 Financial Results Tuesday, October 26, 2010
October 18, 2010 10:34 am | by Bio-Medicine.Org | News | CommentsUNION CITY, Calif., Oct. 18 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the second quarter of fiscal year 2011, ended September 30, 2010. The call will...
Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
October 15, 2010 10:31 am | by Bio-Medicine.Org | News | CommentsCARLSBAD, Calif., Oct. 15 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010 at 11:00 a.m. ET at...
Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
October 15, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsTARRYTOWN, N.Y., Oct. 15 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010. The presentation is scheduled for 9:00 a.m. Eastern Time. The session may be...
Watson's Generic Version of Lotrel ® Receives FDA Approval
October 15, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J., Oct. 15 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine...
Stop Aging Now Named to Prestigious Inc. 5000 List
October 13, 2010 8:33 pm | by Bio-Medicine.Org | News | CommentsBETHESDA, Md., Oct. 13 /- Stop Aging Now has been selected by the editors of Inc. magazine as one of America's fastest-growing private companies. Stop Aging Now , a recognized expert in nutrition and anti-aging, sells high-quality anti-aging vitamins and supplements. (Logo: ...
Nonin Medical's Onyx® II 9560 Wireless Pulse Oximeter Aids Chilean Miner Rescue: Company to Also Donate in-Home Monitoring Equipment for Miners' Post-event Care
October 13, 2010 8:32 pm | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS, Oct. 13 /- Nonin Medical, Inc., the inventor of the world's first fingertip and wireless-fingertip pulse oximeter, announced today that its Onyx® II 9560 wireless fingertip pulse oximeter was used in the effort to rescue 33 Chilean miners who were trapped in a Copiapo,...
Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes
October 12, 2010 4:32 pm | by Bio-Medicine.Org | News | CommentsOAKLAND, Calif., Oct. 12 /- Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study...
People With Disabilities Experience Their Possibilities at Abilities Expo in Atlanta, Georgia
October 12, 2010 6:31 am | by Bio-Medicine.Org | News | CommentsATLANTA, Oct. 12 /- Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on Friday, October 15, through Sunday, October 17, 2010 at the Cobb Galleria Convention Center. Admission is...
InfraReDx Completes $21 Million Equity Financing
October 12, 2010 6:31 am | by Bio-Medicine.Org | News | CommentsBURLINGTON, Mass., Oct. 12 /- InfraReDx, Inc. , a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the completion of a $21 million equity financing. This round of investment attracted new institutions as well as existing...
Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
October 11, 2010 8:32 am | by Bio-Medicine.Org | News | CommentsINDIANAPOLIS, Oct. 11 /- BioStorage Technologies, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, has expanded its sample management offerings to include laboratory sample preparation services,...
Randomized Clinical Trial of OrbusNeich's Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
October 11, 2010 8:31 am | by Bio-Medicine.Org | News | CommentsHONG KONG, Oct. 11 /- OrbusNeich today reported the completion of patient enrollment in a randomized clinical study of its Genous Bio-engineered R stent at 11 sites in China. The primary objective of the 180 patient, controlled study is to demonstrate the safety and effectiveness of the...
